Immunocore Holdings plc
IMCR
$30.22
-$0.51-1.66%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 30.48% | 37.88% | 62.99% | 64.12% | 7.60% |
| Total Depreciation and Amortization | -22.31% | -11.60% | -6.74% | -2.46% | 2.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.53% | -37.89% | -52.62% | -64.19% | -50.38% |
| Change in Net Operating Assets | -119.00% | -59.05% | 28.74% | 4,268.68% | 746.63% |
| Cash from Operations | -141.10% | -64.13% | 198.68% | 355.07% | 786.43% |
| Capital Expenditure | 16.10% | -109.64% | -186.26% | -76.63% | 4.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 96.57% | 96.00% | 94.29% | -- | -- |
| Cash from Investing | 95.40% | 94.61% | 92.87% | -11,988.19% | -6,446.16% |
| Total Debt Issued | -- | -100.00% | -100.00% | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 81.93% | -30.93% | -69.28% | -89.41% | -80.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | 90.88% | -- |
| Cash from Financing | -96.40% | -110.81% | -110.95% | -111.69% | 901.23% |
| Foreign Exchange rate Adjustments | 1,660.83% | -31.80% | 1,039.65% | 42.79% | -120.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.60% | -142.03% | -123.36% | -185.89% | -67.36% |